International Assets Investment Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$946 Hold
100
﹤0.01% 2207
2026
Q1
$802 Hold
100
﹤0.01% 2089
2025
Q4
$672 Buy
+100
New +$754 ﹤0.01% 2076
2024
Q4
Sell
-100
Closed -$1.26K 1505
2024
Q3
$1.26K Hold
100
﹤0.01% 1729
2024
Q2
$1.27K Buy
+100
New +$1.01K ﹤0.01% 2068
2021
Q2
Sell
-10
Closed -$1K 1421
2021
Q1
$1K Hold
10
﹤0.01% 2133
2020
Q4
$1K Buy
+10
New +$1.06K ﹤0.01% 2014

Other funds holding NVAX

International Assets Investment Management's NVAX Position: Q2 2026 in Review

International Assets Investment Management held its Novavax (NVAX) position steady in Q2 2026 at 100 shares worth $946. The position accounts for ﹤0.01% of the portfolio, ranked #2207.

International Assets Investment Management first reported a position in NVAX in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.27K in Q2 2024. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • International Assets Investment Management held 100 shares of Novavax worth $946 as of Q2 2026.
  • International Assets Investment Management left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2207 holding.
  • International Assets Investment Management first reported a position in Novavax in Q4 2020 and has held it in 7 quarters since.
  • International Assets Investment Management's Novavax position peaked at $1.27K in Q2 2024.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.